BioStem Technologies Plans Financial Results Call for 2024
BioStem Technologies to Host Financial Results Conference Call
BioStem Technologies Inc. (OTC: BSEM), a prominent MedTech company, is set to announce its financial results for the fourth quarter and full year of 2024. This significative event is slated for April 14, 2025, and will include a conference call as well as a live webcast starting at 4:30 PM ET.
Details of the Event
The conference call will feature important insights from Jason Matuszewski, the Chief Executive Officer, along with Michael Fortunato, the Chief Financial Officer. Their presentations are expected to provide an overview of the quarter's performance and outline the company's strategies moving forward.
How to Attend
Investors and interested parties can listen to the call via a dedicated conference dial-in number. For those unable to connect directly, the webcast will provide an alternative option to engage with the event live. The following are the necessary details:
- Conference ID: 9695874
- North America Toll-Free Dial-In: (800) 715-9871
- International Toll Dial-In: +1 (646) 307-1963
- Webcast Link: https://events.q4inc.com/attendee/728697228
Stay Connected with BioStem
To keep updated with the latest news and developments from BioStem Technologies, individuals can sign up for the company’s email distribution list through their official website. The company also maintains an active presence on various social media platforms such as Twitter, LinkedIn, and Facebook, allowing easy access to ongoing announcements and innovations.
About BioStem Technologies
Established as a leader in the MedTech sector, BioStem Technologies, Inc. (OTC: BSEM) is dedicated to creating impactful regenerative therapies derived from perinatal tissue. The company’s innovative BioREtain processing method plays a vital role in preserving the integrity of tissue and the growth factors essential for healing. Their products, such as AmnioWrap2™ and VENDAJE® series, are designed to revolutionize advanced wound care.
With an FDA-registered facility that meets stringent AATB accreditation standards, BioStem Technologies exemplifies commitment to quality and safety in manufacturing. Each allograft is meticulously processed to ensure that healthcare professionals can confidently use them in various therapeutic scenarios.
Contact Information
BioStem Technologies, Inc.
Phone: 954-380-8342
Website: www.biostemtechnologies.com
Email: info@biostemtech.com
Twitter: @BSEM_Tech
Frequently Asked Questions
Where can I find the conference call information for BioStem Technologies?
You can find the conference call details, including dial-in numbers and webcast links, on their official website or within the press release about the event.
What is the purpose of the upcoming conference call?
The conference call aims to present BioStem Technologies’ financial performance for the fourth quarter and full year of 2024 and discuss future plans and strategies.
Who will be speaking during the conference?
The conference will feature Jason Matuszewski, CEO, and Michael Fortunato, CFO, who will share insights into the company's quarterly results and outlook.
How can I stay updated on BioStem Technologies news?
You can sign up for their email distribution list and follow their social media channels for all the latest updates and announcements.
What products does BioStem Technologies offer?
BioStem Technologies specializes in placental-derived biologics and offers products such as AmnioWrap2™, VENDAJE®, and other allografts designed for advanced wound care and regenerative therapies.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
